Such-Lupe

STADA securities

STADA Arzneimittel AG
Bad Vilbel

- WKN 725 180  -
- ISIN DE 0007251803 -

Second warning of the sale of unclaimed shares

(This is a non-binding translation of the original German version.)

In the electronic Federal Gazette (‘elektronischer Bundesanzeiger’) of July 29, 2004, we asked our shareholders to take possession of the new shares they are entitled to as a result of the capital increase from existing funds through the conversion of capital reserves and other retained earnings in issued capital pursuant to section §§ 207 of the German Stock Corporation Act (AktG) with a total value of EUR 69,408,066.-. The new shares are to be collected from DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main, acting through dwpbank Deutsche WertpapierService Bank AG, Wildunger Strasse 14, 60487 Frankfurt am Main (Ms. Göttel, division securities counter 2) qua depot credit. In the notification, we advised that the Company, pursuant to section § 214 (2) and (3) of the German Stock Corporation Act (AktG), is entitled and obliged, following three warnings, to sell shares which have not been claimed within one year following the official announcement of this request for the account of the parties.

Following the lapse of the one year deadline on July 29, 2005, we warned, for the first time with publication of August 1, 2005, of the sale of shares which have not been claimed at the issuing office by submitting profit participation certificate no. 11, which serves as proof of entitlement. We hereby warn of the sale for the second time.

This second warning will be followed at an interval of one month by a third warning.

All new shares not claimed within a period of one year after the third warning will be sold at their market price for the account of the parties. Insofar as the parties concerned are unknown, we will place the proceeds of the sale to which they are entitled at the depository of the local court in Frankfurt.

Bad Vilbel, in September 2005

The Executive Board

Here we have provided you with an overview of important facts and information from strategy through business segments, sales networks and the history of STADA Arzneimittel AG. More
The management of STADA Arzneimittel AG introduce themselves! Here you will find the members of the Executive Board, the Supervisory Board and the Advisory Board. More
Here you will find corporate news and ad-hoc releases that you can read directly on your screen or download as a PDF file. Older releases are available for you in our archive. More
Notices in accordance with the German Securities Trading Act (WpHG) as well as the annual document and the annual financial statements of STADA Arzneimittel AG can be viewed here. More

 

(c) 2012 STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Telefon 06101 603-0, Fax 06101 603-259, e-Mail: info@stada.de